Publications en collaboration avec des chercheurs de Hospital Clinic Barcelona (15)

2010

  1. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: Association between elevated plasma endothelin levels and the development of ischaemic events

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 2, pp. 434-442

  2. Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways

    Haematologica, Vol. 95, Núm. 3, pp. 456-463

2009

  1. The spectrum of vascular involvement in giant-cell arteritis: Clinical consequences of detrimental vascular remodelling at different sites

    APMIS

2008

  1. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: A cross-sectional screening of fifty-four prospectively followed patients

    Arthritis Care and Research, Vol. 59, Núm. 3, pp. 422-430

  2. Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 11, pp. 1581-1588

  3. New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 3 SUPPL. 49

2007

  1. Gelatinase expression and proteolytic activity in giant-cell arteritis

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 11, pp. 1429-1435

  2. Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 46, Núm. 3, pp. 304-311

2006

  1. Increased levels of atherosclerosis markers in salt-sensitive hypertension

    American Journal of Hypertension, Vol. 19, Núm. 1, pp. 87-93

2005

  1. Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells

    FASEB Journal, Vol. 19, Núm. 13, pp. 1875-1877

2004

  1. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

    Current rheumatology reports, Vol. 6, Núm. 3, pp. 184-194

  2. Extramedullary multiple myeloma escapes the effect of thalidomide

    Haematologica, Vol. 89, Núm. 7, pp. 832-836

  3. Response to thalidomide in multiple myeloma: Impact of angiogenic factors

    Cytokine, Vol. 26, Núm. 4, pp. 145-148

  4. Tissue production of pro-inflammatory cytokines (IL-1β, TNFα and IL-6) correlates with the intesity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis

    Rheumatology, Vol. 43, Núm. 3, pp. 294-301

2003

  1. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: Angiogenic activity of interleukin-6 as a potential protective mechanism

    Circulation, Vol. 107, Núm. 19, pp. 2428-2434